QQ客服 官方微博 反馈留言

	Co-delivery of sorafenib and VFGF-siRNA via pH-sensitive liposomes for the synergistic treatment of hepatocellular carcinoma
	Yao, Yao; Wang, Tianqi; Liu, Yongjun; Zhang, Na
刊名	ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY
	2019
卷号	47期号:1页码:1374-1383
关键词	Liposomes co-delivery sorafenib VEGF-siRNA HCC therapy
DOI	10.1080/21691401.2019.1596943
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4540707
专题	山东大学
作者单位	Shandong Univ, Sch Pharmaceut Sci, Dept Pharmaceut, Key Lab Chem Biol,Minist Educ, 44 Wenhua Xi Rd,
推荐引用方式 GB/T 7714	Yao, Yao,Wang, Tianqi,Liu, Yongjun,et al. Co-delivery of sorafenib and VFGF-siRNA via pH-sensitive liposomes for the synergistic treatment of hepatocellular carcinoma[J]. ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY,2019,47(1):1374-1383.
APA	Yao, Yao,Wang, Tianqi,Liu, Yongjun,&Zhang, Na.(2019).Co-delivery of sorafenib and VFGF-siRNA via pH-sensitive liposomes for the synergistic treatment of hepatocellular carcinoma.ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY,47(1),1374-1383.
MLA	Yao, Yao,et al."Co-delivery of sorafenib and VFGF-siRNA via pH-sensitive liposomes for the synergistic treatment of hepatocellular carcinoma".ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY 47.1(2019):1374-1383.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。